Dopamine, 6-hydroxydopamine, iron, and dioxygen - Their mutual interactions and possible implication in the development of Parkinson's disease

被引:210
作者
Linert, W
Herlinger, E
Jameson, RF
Kienzl, E
Jellinger, K
Youdim, MBH
机构
[1] UNIV DUNDEE,DEPT CHEM,DUNDEE DD1 4HN,SCOTLAND
[2] HOSP LAINZ,LUDWIG BOLTZMANN INST CLIN NEUROBIOL,A-1130 VIENNA,AUSTRIA
[3] NIH,DEPT HLTH & HUMAN SERV,BETHESDA,MD 20892
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1996年 / 1316卷 / 03期
关键词
Parkinson's disease; dopamine; 6-hydroxydopamine; iron(III); iron(II); manganese(II); Fenton's reagent; nicotine;
D O I
10.1016/0925-4439(96)00020-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The reactions of dopamine (1-amino-2-(3,4-dihydroxyphenyl)-ethane DA), 5-hydroxydopamine (5-OHDA), and 6-hydroxydopamine (6-OHDA), with molecular oxygen - with and without the addition of catalytic amounts of iron(III) and other metal ions - have been studied and the implication of these results with respect to the chemistry involved in the progress of Parkinson's disease is discussed, In the presence of O-2 DA reacts spontaneously without the necessity of metal-ion catalysis under the production of stoichiometric amounts of H2O2, to form initially pink dopaminochrome, which is not stable and reacts further (without the consumption of dioxygen) to form the insoluble polymeric material known as 'melanine'. DA reacts with iron(III) yielding an intermediate 1:1 complex, which decomposes releasing Fe(II) and the semiquinone, which reacts further under involvement of both Fr(III) and dioxygen. 6-OHDA reacts without showing the necessity of such an intermediate, and it is shown to be able to release iron as Fe(II) from ferritine. On the other hand, it is shown (in vitro) that Fe(II) reacts in a Fenton type reaction with DA and the present H2O2 producing 5-OHDA and especially 6-OHDA. Based on these mutual interacting reactions a mechanism for the initiation and progress of Parkinson's disease is suggested. The catalytic effects of some other transition-metal ions are presented and an explanation for the peculiarly toxic effects of manganese(II) is put forward. Finally, a possible reason for the effect that nicotine has in the mitigation of Parkinson's disease is discussed.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 47 条
  • [41] SLIVKA A, 1985, J BIOL CHEM, V280, P15468
  • [42] SELECTIVE INCREASE OF IRON IN SUBSTANTIA-NIGRA ZONA COMPACTA OF PARKINSONIAN BRAINS
    SOFIC, E
    PAULUS, W
    JELLINGER, K
    RIEDERER, P
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (03) : 978 - 982
  • [43] MODULATION BY NEUROMELANIN OF THE AVAILABILITY AND REACTIVITY OF METAL-IONS
    SWARTZ, HM
    SARNA, T
    ZECCA, L
    [J]. ANNALS OF NEUROLOGY, 1992, 32 : S69 - S75
  • [44] THOMAS CE, 1986, J BIOL CHEM, V261, P3064
  • [45] RELATION BETWEEN NICOTINE INTAKE AND ALZHEIMERS-DISEASE
    VANDUIJN, CM
    HOFMAN, A
    [J]. BRITISH MEDICAL JOURNAL, 1991, 302 (6791) : 1491 - 1494
  • [46] THE POSSIBLE ROLE OF IRON IN THE ETIOPATHOLOGY OF PARKINSONS-DISEASE
    YOUDIM, MBH
    BENSHACHAR, D
    RIEDERER, P
    [J]. MOVEMENT DISORDERS, 1993, 8 (01) : 1 - 12
  • [47] YOUDIM MBH, 1990, J NEURAL TRANSM-SUPP, V32, P239